NO20064864L - Spraytorkede farmasoytiske preparater - Google Patents

Spraytorkede farmasoytiske preparater

Info

Publication number
NO20064864L
NO20064864L NO20064864A NO20064864A NO20064864L NO 20064864 L NO20064864 L NO 20064864L NO 20064864 A NO20064864 A NO 20064864A NO 20064864 A NO20064864 A NO 20064864A NO 20064864 L NO20064864 L NO 20064864L
Authority
NO
Norway
Prior art keywords
spray
pharmaceutical preparations
dried pharmaceutical
dried
therapy
Prior art date
Application number
NO20064864A
Other languages
English (en)
Norwegian (no)
Inventor
Vlasios Andronis
Rennan Pan
Kamlesh Rameshchandra Patel
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20064864L publication Critical patent/NO20064864L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20064864A 2004-03-30 2006-10-25 Spraytorkede farmasoytiske preparater NO20064864L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55757104P 2004-03-30 2004-03-30
PCT/US2005/010350 WO2005097077A2 (en) 2004-03-30 2005-03-28 Spray dried pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NO20064864L true NO20064864L (no) 2006-10-25

Family

ID=34956393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064864A NO20064864L (no) 2004-03-30 2006-10-25 Spraytorkede farmasoytiske preparater

Country Status (27)

Country Link
US (1) US20070178151A1 (pl)
EP (1) EP1729734B1 (pl)
JP (1) JP2007530702A (pl)
KR (1) KR20060135000A (pl)
CN (1) CN1933816A (pl)
AR (1) AR048193A1 (pl)
AT (1) ATE387189T1 (pl)
AU (1) AU2005231355B2 (pl)
BR (1) BRPI0508111A (pl)
CA (1) CA2556461A1 (pl)
DE (1) DE602005005033T2 (pl)
DK (1) DK1729734T3 (pl)
ES (1) ES2301003T3 (pl)
HK (1) HK1099213A1 (pl)
HR (1) HRP20080154T3 (pl)
IL (1) IL177606A0 (pl)
IS (1) IS8548A (pl)
MA (1) MA28557B1 (pl)
NO (1) NO20064864L (pl)
NZ (1) NZ549096A (pl)
PE (1) PE20060161A1 (pl)
PL (1) PL1729734T3 (pl)
PT (1) PT1729734E (pl)
RU (1) RU2006138054A (pl)
TW (1) TW200602055A (pl)
WO (1) WO2005097077A2 (pl)
ZA (1) ZA200606670B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506800D0 (en) * 2005-04-04 2005-05-11 Merck Sharp & Dohme New uses
EP1940357A2 (en) * 2005-09-30 2008-07-09 SmithKline Beecham Corporation Pharmaceutical compositions
EP1940358A2 (en) * 2005-09-30 2008-07-09 SmithKline Beecham Corporation Pharmaceutical compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
ATE246677T1 (de) * 1994-05-27 2003-08-15 Smithkline Beecham Farma Chinolinderivate als tachykinin nk3 rezeptor antagonisten
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
DE19501269A1 (de) * 1995-01-18 1996-07-25 Henkel Kgaa Amorphes Alkalisilikat-Compound
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
AU2001262945B2 (en) * 2000-09-20 2006-02-02 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
US6620438B2 (en) * 2001-03-08 2003-09-16 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
MY134211A (en) * 2001-05-18 2007-11-30 Smithkline Beecham Corp Novel use
WO2003030872A2 (en) * 2001-10-12 2003-04-17 Elan Pharma International Ltd. Compositions having a combination of particles for immediate release and for controlled release

Also Published As

Publication number Publication date
RU2006138054A (ru) 2008-05-10
ZA200606670B (en) 2008-01-30
KR20060135000A (ko) 2006-12-28
WO2005097077A3 (en) 2006-04-13
PL1729734T3 (pl) 2008-09-30
CN1933816A (zh) 2007-03-21
JP2007530702A (ja) 2007-11-01
IL177606A0 (en) 2006-12-10
DE602005005033D1 (de) 2008-04-10
ATE387189T1 (de) 2008-03-15
HRP20080154T3 (en) 2008-10-31
PT1729734E (pt) 2008-05-29
AU2005231355A1 (en) 2005-10-20
DE602005005033T2 (de) 2009-03-19
AU2005231355B2 (en) 2008-09-18
BRPI0508111A (pt) 2007-07-17
US20070178151A1 (en) 2007-08-02
EP1729734A2 (en) 2006-12-13
EP1729734B1 (en) 2008-02-27
PE20060161A1 (es) 2006-05-10
HK1099213A1 (en) 2007-08-10
CA2556461A1 (en) 2005-10-20
TW200602055A (en) 2006-01-16
DK1729734T3 (da) 2008-06-16
NZ549096A (en) 2009-05-31
WO2005097077A2 (en) 2005-10-20
AR048193A1 (es) 2006-04-05
IS8548A (is) 2006-10-06
MA28557B1 (fr) 2007-04-03
ES2301003T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
EP3690050A4 (en) MULTISPECIFIC ANTIGEN-BINDING MOLECULE HAVING SUBSTITUTION ACTIVITY FOR THE FUNCTION OF BLOOD COAGULATION FACTOR VIII COFACTOR (FVIII), AND PHARMACEUTICAL FORMULATION CONTAINING THE SAME MOLECULE AS ACTIVE PRINCIPLE
NO20091299L (no) Substituerte sulfonamidderivater
PH12021550992A1 (en) Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors
MY187047A (en) Selective pyy compounds and uses thereof
TN2009000446A1 (en) P70 s6 kinase inhibitors
NO20060001L (no) Nye P2X7-reseptorantagonister og deres anvendelse
ZA202204284B (en) Inhibitors of raf kinases
PH12019501639A1 (en) Jaki selective inhibitors
BR112016008849B8 (pt) Compostos ou sais farmaceuticamente aceitáveis dos mesmos, uso dos referidos compostos e composições farmacêuticas
NO20081844L (no) Terapeutiske forbindelser
SE0301372D0 (sv) Novel compounds
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
NO20090305L (no) Cyklosporin formuleringer
NO20052493D0 (no) Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
MY144972A (en) Novel amide derivative for inhibiting the growth of cancer cells
NO20065190L (no) Farmasoytiske sammensetninger omfattende en amfifil stivelse
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200870545A1 (ru) Новые гетероциклические соединения
NO20082130L (no) 3-Amino-1-arylpropylindoler og aza-substituerte indoler
MX2018013573A (es) Ciertos inhibidores de la proteína cinasa.
NO20052491D0 (no) Nye vitronektinresepotr antagonistderivater, fremgangsmate til deres fremstilling, anvendelse derav som legemidler og farmasoytiske sammensetninger som inneholder de samme
NO20064864L (no) Spraytorkede farmasoytiske preparater
WO2008004100A3 (en) Therapeutic compounds
EP4053151A4 (en) KERATIN BD-1, PREPARATION METHOD, AS WELL AS PHARMACEUTICAL COMPOSITION AND USE THEREOF

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application